Overview

Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
Safety and efficacy study of neoadjuvant chemotherapy (FLOT versus SOX) for gastric cancer patients in high volume center of China
Phase:
Phase 2
Details
Lead Sponsor:
LI CHEN
Ruijin Hospital
Treatments:
Oxaliplatin